15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 15,100 shares of the life sciences company's stock, valued at approximately $342,000.

A number of other hedge funds also recently modified their holdings of IART. Nisa Investment Advisors LLC lifted its stake in Integra LifeSciences by 599.6% during the fourth quarter. Nisa Investment Advisors LLC now owns 3,267 shares of the life sciences company's stock worth $74,000 after purchasing an additional 2,800 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Integra LifeSciences by 33.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 19,755 shares of the life sciences company's stock valued at $448,000 after buying an additional 4,967 shares in the last quarter. Nordea Investment Management AB grew its position in Integra LifeSciences by 4.1% in the fourth quarter. Nordea Investment Management AB now owns 127,908 shares of the life sciences company's stock valued at $2,919,000 after acquiring an additional 5,032 shares during the last quarter. Choreo LLC grew its holdings in shares of Integra LifeSciences by 29.9% during the 4th quarter. Choreo LLC now owns 22,274 shares of the life sciences company's stock valued at $500,000 after purchasing an additional 5,123 shares during the last quarter. Finally, Empowered Funds LLC bought a new stake in shares of Integra LifeSciences in the 4th quarter valued at $180,000. Institutional investors and hedge funds own 84.78% of the company's stock.

Integra LifeSciences Stock Up 0.1 %

NASDAQ IART traded up $0.01 on Monday, reaching $19.58. The company had a trading volume of 770,282 shares, compared to its average volume of 1,045,530. The company's fifty day moving average is $23.37 and its 200 day moving average is $22.34. The stock has a market capitalization of $1.51 billion, a P/E ratio of -217.53, a P/E/G ratio of 0.73 and a beta of 1.24. The company has a quick ratio of 0.73, a current ratio of 1.20 and a debt-to-equity ratio of 0.79. Integra LifeSciences Holdings Co. has a 52-week low of $16.81 and a 52-week high of $34.79.

Remove Ads

Integra LifeSciences (NASDAQ:IART - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The life sciences company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.12. Integra LifeSciences had a positive return on equity of 12.35% and a negative net margin of 0.42%. The company had revenue of $442.65 million during the quarter, compared to analyst estimates of $445.15 million. During the same quarter last year, the firm posted $0.89 EPS. The firm's revenue for the quarter was up 11.5% on a year-over-year basis. Sell-side analysts anticipate that Integra LifeSciences Holdings Co. will post 2.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Argus raised Integra LifeSciences from a "hold" rating to a "buy" rating in a research note on Monday, March 31st. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $23.00.

Integra LifeSciences Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.